Authors:
Zannis, VI
Kan, HY
Kritis, A
Zanni, EE
Kardassis, D
Citation: Vi. Zannis et al., Transcriptional regulatory mechanisms of the human apolipoprotein genes invitro and in vivo, CURR OP LIP, 12(2), 2001, pp. 181-207
Authors:
Kypreos, KE
van Dijk, KW
van der Zee, A
Havekes, LM
Zannis, VI
Citation: Ke. Kypreos et al., Domains of apolipoprotein E contributing to triglyceride and cholesterol homeostasis in vivo - Carboxyl-terminal region 203-299 promotes hepatic verylow density lipoprotein-triglyceride secretion, J BIOL CHEM, 276(23), 2001, pp. 19778-19786
Authors:
Reardon, CA
Kan, HY
Cabana, V
Blachowicz, L
Lukens, JR
Wu, QZ
Liadaki, K
Getz, GS
Zannis, VI
Citation: Ca. Reardon et al., In vivo studies of HDL assembly and metabolism using adenovirus-mediated transfer of apoA-I mutants in apoA-I-deficient mice, BIOCHEM, 40(45), 2001, pp. 13670-13680
Authors:
Kypreos, KE
Morani, P
van Dijk, KW
Havekes, LM
Zannis, VI
Citation: Ke. Kypreos et al., The amino-terminal 1-185 domain of ApoE promotes the clearance of lipoprotein remnants in vivo. The carboxy-terminal domain is required for inductionof hyperlipidemia in normal and ApoE-deficient mice, BIOCHEM, 40(20), 2001, pp. 6027-6035
Citation: D. Kardassis et al., SMAD proteins transactivate the human apoCIII promoter by interacting physically and functionally with hepatocyte nuclear factor 4, J BIOL CHEM, 275(52), 2000, pp. 41405-41414
Authors:
Liadaki, KN
Liu, T
Xu, SZ
Ishida, BY
Duchateaux, PN
Krieger, JP
Kane, J
Krieger, M
Zannis, VI
Citation: Kn. Liadaki et al., Binding of high density lipoprotein (HDL) and discoidal reconstituted HDL to the HDL receptor scavenger receptor class B type I - Effect of lipid association and APOA-I mutations on receptor binding, J BIOL CHEM, 275(28), 2000, pp. 21262-21271
Authors:
Gorshkova, IN
Liadaki, K
Gursky, O
Atkinson, D
Zannis, VI
Citation: In. Gorshkova et al., Probing the lipid-free structure and stability of apolipoprotein A-I by mutation, BIOCHEM, 39(51), 2000, pp. 15910-15919
Citation: P. Pissios et al., SREBP-1 binds to multiple sites and transactivates the human apoA-II promoter in vitro - SREBP-1 mutants defective in DNA binding or transcriptional activation repress apoA-II promoter activity, ART THROM V, 19(6), 1999, pp. 1456-1469
Citation: Hy. Kan et al., DNA binding specificity and transactivation properties of SREBP-2 bound tomultiple sites on the human apoA-II promoter, NUCL ACID R, 27(4), 1999, pp. 1104-1117
Authors:
Lavrentiadou, SN
Hadzopoulou-Cladaras, M
Kardassis, D
Zannis, VI
Citation: Sn. Lavrentiadou et al., Binding specificity and modulation of the human ApoCIII promoter activity by heterodimers of ligand-dependent nuclear receptors, BIOCHEM, 38(3), 1999, pp. 964-975
Authors:
Aleshkov, SB
Li, XP
Lavrentiadou, SN
Zannis, VI
Citation: Sb. Aleshkov et al., Contribution of cysteine 158, the glycosylation site theonine 194, the amino- and carboxy-terminal domains of apolipoprotein E in the binding to amyloid peptide beta (1-40), BIOCHEM, 38(28), 1999, pp. 8918-8925